Source: Slovak Spectator

The Health Ministry approved the therapeutic use of Ivermectin for six months.

Ivermectin, a medication used to treat many types of parasite infestations, can now be used to treat coronavirus patients in hospitals and obtained from pharmacies with a prescription.

The Health Ministry approved the therapeutic use of this medication for six months. It will be used with other treatments, its spokesperson Zuzana Eliášová said, as reported by the TASR newswire.

The medication can be legally imported to Slovakia and given to patients. With such a step, the ministry fulfilled the request of the association of Slovak anaesthetists, the Denník N daily reported.






Related: HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

Use of Ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt : A randomised clinical trial

IVERMECTIN IS INCLUDED IN COVID-19 TREATMENT AGAIN: Peru

La Pampa will begin to treat coronavirus patients with Ivermectin: Argentina

Malaysia to run trials for 2 drugs in Covid-19 treatment, including Ivermectin

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »